Chargement en cours...
Silencing of CXCR4 sensitizes triple-negative breast cancer cells to cisplatin
Triple-negative breast cancer (TNBC) is an aggressive form of breast cancer for which there is no effective treatment. Previously, we and others demonstrated that CXCR4 surface expression is an independent prognostic factor for disease relapse and survival in breast cancer. In this study, we investi...
Enregistré dans:
| Publié dans: | Oncotarget |
|---|---|
| Auteurs principaux: | , , , , , , , |
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Impact Journals LLC
2014
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4359214/ https://ncbi.nlm.nih.gov/pubmed/25544759 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|